跳至主要内容
临床试验/NCT00971282
NCT00971282已完成4 期

Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins

Galderma R&D1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Galderma R&D
入组人数
30
试验地点
1
主要终点
Pruritus

研究概览

简要总结

This is a single-center study, randomized, Investigator/Evaluator-blinded bilateral (split-face) comparison.

The objective: To assess the benefit of the concomitant use of a Moisturizing Lotion in reducing the skin irritation induced by a adapalen gel treatment in Chinese Subjects.

详细描述

The interest & relevance of the concomitant use of a non-comedogenic moisturizer in order to decrease retinoid irritation has already been demonstrated in Caucasian patients. Such interest of associating a moisturizer when Differin® gel is prescribed has not been demonstrated in Asian populations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female subjects of Chinese origins
  • aged 21 years or older
  • with healthy skin;

排除标准

  • skin pigmentation which interferes with the reading of skin reactions
  • with sunburn, eczema, atopic dermatitis, perioral dermatitis, or rosacea on the area to be treated
  • with a washout period for the following topical treatment(s) Corticosteroids, oher anti-inflammatory drugs, retinoids
  • with a washout period for the following systemic treatment(s): Medications that may increase photosensitivity, corticosteroids, anti-inflammatories, retinoids

研究组 & 干预措施

intra-individual comparison

Experimental

干预措施: adapalen 0.1% (Drug)

intra-individual comparison

Experimental

干预措施: Cetaphil® (Other)

结局指标

主要结局

Pruritus

时间窗: at 4 weeks

score from 0 (none) to 3 (severe)

Scaling

时间窗: at 4 weeks

score from 0 (none) to 3 (severe)

Dryness

时间窗: at 4 weeks

score from 0 (none) to 3 (severe)

Stinging/Burning

时间窗: at 4 weeks

score from 0 (none) to 3 (severe)

Erythema Rating Scale

时间窗: at 4 weeks

score from 0 (none) to 3 (severe)

次要结局

未报告次要终点

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验